IDEAYA Biosciences, Inc. (IDYA)
36.11
+0.05
(+0.14%)
USD |
NASDAQ |
Oct 09, 16:00
35.60
-0.51
(-1.41%)
After-Hours: 19:35
IDEAYA Biosciences Max Drawdown (5Y) : 69.42% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 69.42% |
| August 31, 2026 | 69.42% |
| July 31, 2026 | 69.42% |
| June 30, 2026 | 69.42% |
| May 31, 2026 | 69.42% |
| April 30, 2026 | 69.42% |
| March 31, 2026 | 69.42% |
| February 28, 2026 | 69.42% |
| January 31, 2026 | 69.42% |
| December 31, 2025 | 69.42% |
| November 30, 2025 | 69.42% |
| October 31, 2025 | 69.42% |
| September 30, 2025 | 69.42% |
| August 31, 2025 | 69.42% |
| July 31, 2025 | 69.42% |
| June 30, 2025 | 69.42% |
| May 31, 2025 | 69.42% |
| April 30, 2025 | 69.42% |
| March 31, 2025 | 69.96% |
| February 28, 2025 | 74.64% |
| January 31, 2025 | 74.64% |
| December 31, 2024 | 74.64% |
| November 30, 2024 | 74.64% |
| October 31, 2024 | 74.64% |
| September 30, 2024 | 74.64% |
| Date | Value |
|---|---|
| August 31, 2024 | 74.64% |
| July 31, 2024 | 74.64% |
| June 30, 2024 | 74.64% |
| May 31, 2024 | 74.64% |
| April 30, 2024 | 74.64% |
| March 31, 2024 | 74.64% |
| February 29, 2024 | 74.64% |
| January 31, 2024 | 74.64% |
| December 31, 2023 | 74.64% |
| November 30, 2023 | 74.64% |
| October 31, 2023 | 74.64% |
| September 30, 2023 | 74.64% |
| August 31, 2023 | 74.64% |
| July 31, 2023 | 74.64% |
| June 30, 2023 | 74.64% |
| May 31, 2023 | 74.64% |
| April 30, 2023 | 74.64% |
| March 31, 2023 | 74.64% |
| February 28, 2023 | 74.64% |
| January 31, 2023 | 74.64% |
| December 31, 2022 | 74.64% |
| November 30, 2022 | 74.64% |
| October 31, 2022 | 74.64% |
| September 30, 2022 | 74.64% |
| August 31, 2022 | 74.64% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| MediciNova, Inc. | 90.32% |
| Ironwood Pharmaceuticals, Inc. | 96.33% |
| Xencor, Inc. | 87.01% |
| Viking Therapeutics, Inc. | 89.26% |
| UroGen Pharma Ltd. | 92.16% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 5.129 |
| Beta (5Y) | -0.0362 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 56.20% |
| Historical Sharpe Ratio (5Y) | 0.0848 |
| Historical Sortino (5Y) | 0.1722 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 20.58% |